UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Timothy Donahue, MD

Print
Email

Timothy Donahue, MD

UCLA Physician Timothy Donahue, MD specializes in Surgery.
Specialty
Surgery
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A86040
Contact
(310) 794-7788 Patient Appointments
(310) 825-9427 Surgery Scheduling
(310) 206-7440 Academic Office
Fax Number
(310) 206-2472
Email Address
tdonahue@mednet.ucla.edu
PRACTICE LOCATION

UCLA General Surgery
200 UCLA Medical Plaza, Suite 214
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Surgery, American Board of Surgery, 2010
EDUCATION
Residency
Surgery, UCLA School of Medicine, 2003 - 2009
Internship
Surgery, UCLA School of Medicine, 2002 - 2003
Degree
MD, Northwestern University Feinberg School of Medicine, 2002
CLINICAL INTEREST
Achalasia (Laparosopic), Bile Duct Excision for benign & malignant disease, Cholecystectomy, Colon Cancer, Colon Polyps, Colon Tumor (Benign), Colorectal (colon, rectum and anus), Diverticulitis, Duodenal Ulcer Disease, Fundoplication, Gallbladder, Gallstone, Gastrectomy, Gastric Cancer, Gastric Polyps, Gastrointestinal Surgery, GERD (Gastroesophageal Reflux Disease), Hepatobiliary, Hernia Repair ( Epigastric Hernia), Hernia Repair (Femoral Hernia), Hernia Repair (Inguinal Hernia), Hernia Repair (Umbilical Hernia), Hiatal Hernia, Laparoscopic Surgery, Minimally Invasive Surgery, Oncology, Pancreatic Cancer, Pancreatic Tumor (Benign), Paraesophageal Diverticulum, Peptic Ulcer Disease (PUD) Surgery, Periampullary Mass, Sigmoid Cecal Volvulus, Small Bowel Internal Fistula ( Open & Lap), Splenectomy (Open & Lap), Stomach Cancer, Stomach Tumor (Benign), Urgent Gastrointestinal Surgery, Whipple & Pancreatectomy
AFFILIATION
MORE INFORMATION
Research Interest
Molecular genetics of pancreatic cancer
Additional Information
Timothy Donahue, M.D. is an Assistant Professor of Surgery, and Molecular and Medical Pharmacology. He is also a member of the UCLA Center for Pancreatic Diseases. Dr. Donahue received his M.D. from the Feinberg School of Medicine at Northwestern and completed his surgical training at UCLA. He specializes in pancreatic and abdominal laparoscopic surgery.
Dr. Donahue also runs an active research laboratory. He is a member of the Jonsson Comprehensive Cancer Center and Institute for Molecular Medicine at UCLA. His laboratory focuses on the molecular genetics of pancreatic cancer. He is particularly interested in identifying novel molecular markers to improve the diagnosis, treatment, and ultimately prognosis of patients with pancreatic cancer. He is also collaborating with a number of researchers across UCLA to develop improved imaging and treatment strategies for his patients. His research program is supported by grants from many national foundations.
Awards & Recognition
  • 2012 STOP CANCER Armand Hammer Career Development Award
  • 2009 Ronald K. Tompkins Golden Apple Award for Most Outstanding Medical Student Teaching
  • 2009 Outstanding Medical Student Teaching Award, UCLA
  • 2008 American Society of Clinical Oncology Foundation Merit Award Recipient
  • 2006 Outstanding Medical Student Teaching Award, UCLA  
  • 2005 Outstanding Medical Student Teaching Award, UCLA
Publications
  1. Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer.  Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Hargan Calvopina J, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H. Clin Cancer Res. 2012 Jan 18. [Epub ahead of print]
  2. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3. Quatromoni JG, Morris LF, Donahue TR, Wang Y, McBride W, Chatila T, Economou JS. J Hematol Oncol. 2011 Nov 23;4:48.
  3. Nodal/Activin signaling: a novel target for pancreatic cancer stem cell therapy. Donahue TR, Dawson DW. Cell Stem Cell. 2011 Nov 4;9(5):383-4.
  4. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. Donahue TR, Isacoff WH, Hines OJ, Tomlinson JS, Farrell JJ, Bhat YM, Garon E, Clerkin B, Reber HA. Arch Surg. 2011 Jul;146(7):836-43.
  5. Operative blood loss and survival in pancreatic cancer. Donahue TR, Reber HA. Pancreas. 2011 Jan;40(1):1-2. No abstract available.
  6. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. Hill R, Calvopina JH, Kim C, Wang Y, Dawson DW, Donahue TR, Dry S, Wu H. Cancer Res. 2010 Sep 15;70(18):7114-24. Epub 2010 Aug 31.
  7. Cystic neoplasms of the pancreas: results of 114 cases. Donahue TR, Hines OJ, Farrell JJ, Tomlinson JS, Eibl G, Reber HA. Pancreas. 2010 Nov;39(8):1271-6.
  8. Pancreatic surgery. Donahue TR, Reber HA. Curr Opin Gastroenterol. 2010 Sep;26(5):499-505. Review.
  9. Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram. Donahue TR, Kattan MW, Nelson SD, Tap WD, Eilber FR, Eilber FC. Cancer. 2010 Aug 15;116(16):3883-91.
  10. Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer. Donahue TR, Kazanjian KK, Isacoff WH, Reber HA, Hines OJ. J Gastrointest Surg. 2010 Jun;14(6):1012-8. Epub 2010 Mar 23.
  11. Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. Vo DD, Prins RM, Begley JL, Donahue TR, Morris LF, Bruhn KW, de la Rocha P, Yang MY, Mok S, Garban HJ, Craft N, Economou JS, Marincola FM, Wang E, Ribas A. Cancer Res. 2009 Nov 15;69(22):8693-9. Epub 2009 Oct 27.
  12. Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade. Ribas A, Comin-Anduix B, Economou JS, Donahue TR, de la Rocha P, Morris LF, Jalil J, Dissette VB, Shintaku IP, Glaspy JA, Gomez-Navarro J, Cochran AJ. Clin Cancer Res. 2009 Jan 1;15(1):390-9.
  13. CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer. Donahue TR, Hines OJ. World J Surg. 2009 Apr;33(4):710-5. Review. Collagenase and surgical disease. Donahue TR, Hiatt JR, Busuttil RW. Hernia. 2006 Dec;10(6):478-85. Review.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Timothy Donahue, click here to update your profile.